Elizabeth Shpall

11PUBLICATIONS
210CO-AUTHORS
Medical infection agents (incl. prions)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyReaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Dec 10, 2025
Clinical Outcomes of Adult Patients With Newly Diagnosed Mixed Phenotype Acute Leukemia.

Hannah Goulart, Farhad Ravandi, Nicholas J Short

|Oct 27, 2025
CD70-Targeting CAR NK Cells Overcome BCMA Downregulation and Improve Survival in High-risk Multiple Myeloma Models.

Paul Lin, Sunil Acharya, Francia Reyes-Silva

|Aug 25, 2025
High-Dose Chemotherapy for Multiply or Poor-Risk Relapsed Germ Cell Tumors.

Yago Nieto, John F Ward, Wayne Hofstetter

|Jan 13, 2025
Enhancement of High-Dose Chemotherapy and Autologous SCT with the PARP Inhibitor Olaparib for Refractory Lymphoma.

Yago Nieto, Jeremy Ramdial, Benigno Valdez

|Sep 11, 2024
BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML.

Bijender Kumar, Anand Singh, Rafet Basar

|Jun 20, 2024
CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis.

Sunil Acharya, Rafet Basar, May Daher

Pageof 2

Frequent Collaborators

5 joint publications

Katayoun Rezvani

5 joint publications

May Daher

4 joint publications

Rafet Basar

4 joint publications

Hind Rafei